Ultrasound-Activated Nanobubbles Induce Durable Systemic Antitumor Immunity.

Area of Science:

• Oncology
• Biomedical Engineering
• Immunology

Background:

• Aggressive breast cancer often features a tumor microenvironment that suppresses immune responses, hindering effective immunotherapy.
• Key suppressive factors include low antigen load, poor antigen presentation, T cell exhaustion, and a rigid extracellular matrix impeding immune cell movement.

Purpose of the Study:

• To investigate ultrasound (US)-activated nanobubbles (NBs) as a drug-free intervention to overcome the immunosuppressive tumor microenvironment in breast cancer.
• To evaluate the ability of US-NBs to restore immune cell infiltration and generate durable antitumor immunity.

Main Methods:

• Utilized perfluoropropane-filled nanoparticles (nanobubbles) that penetrate tumors and, upon ultrasound activation, exert mechanical forces.
• Assessed the impact of US-NB treatment on immune cell populations, extracellular matrix properties, and tumor rejection in syngeneic triple-negative and luminal B-like breast cancer models.

Main Results:

• US-NB treatment rapidly depleted immunosuppressive myeloid cells and increased the ratio of antigen-experienced to suppressive T cells.
• Achieved significant infiltration of CD4+ and CD8+ T cells within 48 hours, leading to an 85% cure rate in one model.
• Demonstrated durable systemic immune memory and therapeutic benefits across different breast cancer subtypes.

Conclusions:

• US-NB mechanical immunomodulation represents a promising drug-free therapeutic strategy for breast cancer.
• This approach leverages biophysical tissue properties to generate robust, long-lasting antitumor immunity, overcoming limitations of current immunotherapies.